Subscribe To
Gsk boosts profit forecasts after ‘outstanding' rsv vaccine launch
High demand for the vaccine pulled in around $850 million during the third quarter—reportedly double what analysts were expecting—and ...
November 1, 2023, 6:38 am
gsk says endometrial cancer drug meets primary goal in late-stage trial
British drugmaker gsk said on Monday its cancer drug Jemperli met the primary goal of overall survival ...
October 30, 2023, 3:16 am
gsk shingles vaccine to underpin third quarter update
Strong sales of its shingles vaccine Shingrix has already seen GSK upgrade its forecasts for 2023. The pharmaceutical giant now expects turnover to...
October 27, 2023, 7:21 am
Rsv vaccine from gsk shows potential to protect adults 50 to 59
The results suggest that GSK's shot could help protect a wider population from RSV, which causes thousands of hospitalizations and deaths each year....
October 25, 2023, 8:42 am
Rsv vaccine shows hopeful early results in 50 to 59-year-olds, gsk says
gsk said they plan to submit data to regulators as soon as possible and expect a decision in 2024 on wh...
October 25, 2023, 5:38 am
Gsk says latest arexvy respiratory vaccine trial results ‘positive'
GSK PLC (LSE:GSK, NYSE:GSK) today unveiled ‘positive' preliminary results from the third phase of its trial of Arexvy, a vaccine against the potenti...
October 25, 2023, 4:32 am
Gsk's rsv vaccine shows positive results in adults aged 50-59
British drugmaker gsk said on Wednesday its vaccine for respiratory syncytial virus (RSV) showed potent...
October 25, 2023, 2:25 am
gsk settlement keeps it on course to remove zantac overhang by early 2024, analyst says
GSK PLC's (LSE:GSK, NYSE:GSK) latest out-of-court Zantac deal is important to the ongoing "overhang" over the investment case, Citigroup said. The U...
October 12, 2023, 8:44 am
gsk settles zantac cases after claims popular heartburn drug causes cancer
The pharma giant settled four cases in California for an undisclosed amount to avoid the “distraction” of a trial....
October 11, 2023, 8:30 am
gsk strikes legal settlement over heartburn drug zantac
GSK PLC (LSE:GSK, NYSE:GSK) has struck a deal to stop a high profile case concerning its heartburn drug Zantac heading to court in California. The FTS...
October 11, 2023, 2:24 am
gsk signs shingles vaccine deal with china's zhifei for about $3 bln
GSK , on Monday, announced an exclusive partnership with China's Chongqing Zhifei Biological Products (Zhifei) for its shingles vaccine....
October 9, 2023, 2:18 am
Is gsk stock worth buying right now?
British drugmaker GSK has been in reorganization mode since 2017. The new gsk should sport higher growt...
July 29, 2023, 7:30 pm
gsk settlement clears much if the the zantac liability 'overhang', says us bank
GSK PLC (LSE:GSK, NYSE:GSK)'s settlement with a California plaintiff over an alleged link between Zantac and cancer "clears 80%+ of the liability ove...
June 26, 2023, 9:19 am
gsk settles zantac cancer lawsuit set to go to trial next month
American depositary receipts of GSK jumped after the U.K.-based biopharma company said it had reached a settlement in a lawsuit accusing the firm's di...
June 23, 2023, 4:30 pm
gsk shares jump 5% after settlement reached on zantac ahead of california trial
gsk shares jump 5% after settlement reached on Zantac ahead of California trial Read Full Story The pos...
June 23, 2023, 9:03 am
: gsk shares surge after reaching settlement on zantac ahead of california trial
GSK UK:gsk shares surged 6% in London action as the U.K. pharmaceutical said it reached a settlement ov...
June 23, 2023, 9:00 am
gsk stock climbs on zantac settlement
GSK's settlement with a plaintiff in California over claims Zantac can cause cancer avoids a trial and brings it into line with industry peers....
June 23, 2023, 7:55 am
gsk shares up 3.4% after zantac settlement
Shares in GSK PLC (LSE:GSK, NYSE:GSK) rose by 3.4% following the announcement of a confidential settlement reached by the UK pharmaceutical group con...
June 23, 2023, 3:18 am
gsk says rsv vaccine for older adults provides protection over two seasons
GlaxoSmithKline's new clinical trial results suggest seniors may only need to take the pharmaceutical company's RSV shot every other year....
June 21, 2023, 10:38 am
Rsv vaccine for older adults provides protection over two seasons, gsk says
GSK's GSK, -1.51% respiratory syncytial virus vaccine for older adults may protect against disease for two full RSV seasons, according to new results ...
June 21, 2023, 8:40 am